GAS6 and pancreatic neoplasm: This latter idea might offer a molecular explanation that the in vivo administration of warfarin could block the Gas6-Axl signaling complex in a pancreatic cancer model (29), as well as that warfarin exerts an antimetastatic action in mice via the Cbl-Gas6-TAM axis in NK cells (25).